Phase II Trial of Dasatinib in Combination With Weekly Paclitaxel for Patients with Metastatic Breast Carcinoma

被引：0
|
作者：
Morris, P. G. [1 ]
Lake, D. [1 ]
McArthur, H. L. [1 ]
Gilewski, T. [1 ]
Dang, C. [1 ]
Chaim, J. [1 ]
Patl, S. [1 ]
Lim, K. [1 ]
Norton, L. [1 ]
Hudis, C. A. [1 ]
Fornier, M. N. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/0008-5472.SABCS12-P5-20-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-20-07
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Phase I-II Trial of Dasatinib (D) in Combination with Weekly (w) Paclitaxel (P) for Patients (Pts) with Metastatic Breast Carcinoma (MBC)
    Morris, P. G.
    Abbruzzi, A.
    D'Andrea, G.
    Gilewski, T.
    Lake, D.
    Bromberg, J.
    Dang, C.
    Dickler, M.
    Modi, S.
    Seidman, A. D.
    Sklarin, N.
    Chang, J.
    Patil, S.
    Norton, L.
    Hudis, C. A.
    Fornier, M. N.
    CANCER RESEARCH, 2010, 70
  • [2] Dasatinib (D) in combination with weekly (w) paclitaxel (P) for patients (pts) with metastatic breast carcinoma (MBC): A phase I/II study
    Fornier, M. N.
    Morris, P. G.
    Abbruzzi, A.
    D'Andrea, G.
    Gilewski, T.
    Bromberg, J.
    Dang, C. T.
    Dickler, M. N.
    Norton, L.
    Hudis, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] A PHASE I-II STUDY OF DASATINIB (D) IN COMBINATION WITH WEEKLY (W) PACLITAXEL (P) FOR PATIENTS (PTS) WITH METASTATIC BREAST CARCINOMA (MBC)
    Fornier, M. N.
    Morris, P. G.
    Abbruzzi, A.
    D'Andrea, G.
    Gilewski, T.
    Lake, D.
    Norton, L.
    Chang, J.
    Hudis, C.
    ANNALS OF ONCOLOGY, 2010, 21 : 110 - 110
  • [4] Correlative biomarkers in a phase II study of dasatinib (D) and weekly (w) paclitaxel (P) for patients (Pts) with metastatic breast carcinoma (MBC)
    Morris, P. G.
    Chang, J. C.
    Abbruzzi, A.
    Patil, S.
    Modi, S.
    Seidman, A. D.
    Sklarin, N. T.
    Norton, L.
    Hudis, C.
    Fornier, M. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer
    Fornier, M. N.
    Morris, P. G.
    Abbruzzi, A.
    D'Andrea, G.
    Gilewski, T.
    Bromberg, J.
    Dang, C.
    Dickler, M.
    Modi, S.
    Seidman, A. D.
    Sklarin, N.
    Chang, J.
    Norton, L.
    Hudis, C. A.
    ANNALS OF ONCOLOGY, 2011, 22 (12) : 2575 - 2581
  • [6] Weekly pegylated liposomal doxorubicin and paclitaxel in patients with metastatic breast carcinoma: A phase II study
    Leonardi, Vita
    Palmisano, Valentina
    Pepe, Alessio
    Usset, Antonella
    Manuguerra, Giovanna
    Savio, Giuseppina
    De Bella, Manuela Tamburo
    Laudani, Agata
    Alu, Massimo
    Cusimano, Maria Pia
    Scianna, Caterina
    Giresi, Armando
    Agostara, Biagio
    ONCOLOGY LETTERS, 2010, 1 (04) : 749 - 753
  • [7] Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients
    Ramaswamy, Bhuvaneswari
    Elias, Anthony D.
    Kelbick, Nicole T.
    Dodley, Angela
    Morrow, Mark
    Hauger, Marsha
    Allen, Joan
    Rhoades, Chris
    Kendra, Kari
    Chen, Helen X.
    Eckhardt, S. Gail
    Shapiro, Charles L.
    CLINICAL CANCER RESEARCH, 2006, 12 (10) : 3124 - 3129
  • [8] Weekly paclitaxel in metastatic breast cancer patients: A phase II study
    Gori, S
    Mosconi, AM
    Basurto, C
    Cherubini, R
    De Angelis, V
    Tonato, M
    Colozza, M
    TUMORI, 2002, 88 (06) : 470 - 473
  • [9] Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer
    Perez, EA
    Vogel, CL
    Irwin, DH
    Kirshner, JJ
    Patel, R
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (22) : 4216 - 4223
  • [10] Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma
    Tan, EH
    Khoo, KS
    Wee, J
    Fong, KW
    Lee, KS
    Lee, KM
    Chua, ET
    Tan, T
    Khoo-Tan, HS
    Yang, TL
    Au, E
    Tao, M
    Ong, YK
    Chua, EJ
    ANNALS OF ONCOLOGY, 1999, 10 (02) : 235 - 237
12345